Group 1: Industry Development - The organic pigment industry, particularly azo organic pigments, is evolving towards environmental protection, high performance, and functionality due to stricter environmental regulations, downstream industry upgrades, and growing demand in emerging markets [1] - The company has products that meet EU environmental regulations set for after 2028, positioning itself as a leader in compliance with high standards [1] - The company emphasizes R&D investment in green processes and high-value-added products, collaborating with downstream industries to innovate and maintain market share [1] Group 2: R&D Projects - The company has disclosed nearly 20 major R&D projects, including a new red pigment suitable for UV curing technology, which has completed validation and aims to penetrate the high-growth UV curing market [1] - A functional material that meets customer-specified spectral characteristics is currently in customer trials, achieving an absorption rate of ≥95% in target bands, enhancing the company's position in the specialty materials market [1] Group 3: New Ventures - The company has established a subsidiary, Qichen Semiconductor New Materials, to enter the photoresist field, focusing on the R&D and production of styrene-based photoresist monomers and resins, creating a new profit growth point [1] - The initial design capacity for this project is 200 tons per year, with plans to expand production based on market demand [1] Group 4: Investment Activities - In July, the company announced a 120 million yuan investment in Zhuoguangrui Technology, acquiring a 19.3548% stake to support the development of domestic projection exposure machines and related components [2] - The company has the option to invest an additional 120 million yuan within six months, potentially increasing its stake in Zhuoguangrui to 36.4977% [2] - Zhuoguangrui's subsidiary, Gangjing Optical Technology, has achieved significant sales growth this year, with advance payments exceeding 50 million yuan [2] Group 5: Financial Performance - In the first half of 2025, the company reported revenue of 269 million yuan, a year-on-year increase of 4.15%, and a net profit attributable to shareholders of 33.757 million yuan, up 21.62% year-on-year [4] - The report indicates that this marks the sixth consecutive quarter of year-on-year growth in both revenue and net profit [4]

Core Viewpoint - United Chemical (301209.SZ) reported its semi-annual results for 2025, highlighting significant institutional investor interest with a total holding of 61.35 million shares, representing 54.78% of the company's total equity [1] Institutional Holdings - As of August 25, 2025, six institutional investors disclosed their holdings in United Chemical, collectively owning 61.35 million shares, which accounts for 54.78% of the total share capital [1] - The institutional ownership increased by 0.98 percentage points compared to the previous quarter [1] Public Fund Disclosure - During this reporting period, one public fund, Bohai Huijin New Momentum Theme Mixed A, was disclosed, which had not been reported in the previous quarter [1]

Group 1 - The company has decided to postpone the implementation of the "annual production of 8,000 tons of organic pigment production project" due to the current market conditions where supply exceeds demand, and the industry capacity growth is expected to outpace demand growth [1][2] - The company aims to enhance its independent research and development capabilities for key technologies of its leading products, providing technical support for the upgrade of high-performance organic pigment products and new growth points [1][2] - The company has indicated that the demand for new varieties of organic pigments from downstream customers has slowed down, and it will focus its R&D efforts based on customer needs [1][2] Group 2 - The company has conducted six inquiries into the special account for raised funds, ensuring compliance with internal regulations and effective execution of relevant rules [1] - The company has not reported any issues requiring attention, and there have been no instances of unfulfilled commitments or significant changes in financial status, management, or core technology [2] - The company has not conducted any training sessions or reported any matters requiring regulatory measures [2]

截至发稿，联合化学市值为100亿元。 每经AI快讯，联合化学（SZ 301209，收盘价：89.5元）8月25日晚间发布公告称，公司第二届第九次董 事会会议于2025年8月25日在公司二楼会议室以现场结合通讯方式召开。会议审议了《关于公司2025年 半年度报告及其摘要的议案》等文件。 （记者 胡玲） 2024年1至12月份，联合化学的营业收入构成为：化工占比99.92%，其他业务占比0.08%。 每经头条（nbdtoutiao）——租下2.5万亩"试验田"，兽医学博士在非洲种粮：首季亩产250斤，打算扩至 10万亩，月薪1~2万元招人 ...

金融界消息 截至2025年8月25日收盘，联合化学（301209）报收于89.5元，下跌2.29%，换手率3.59%， 成交量1.95万手，成交金额1.75亿元。 资金流向方面，今日主力资金净流出2478.72万元，占比成交额14.19%。其中，超大单净流出1862.54万 元、占成交额10.66%，大单净流出616.18万元、占成交额3.53%，中单净流出流入451.62万元、占成交 额2.58%，小单净流入2027.11万元、占成交额11.6%。 通过天眼查大数据分析，龙口联合化学股份有限公司共对外投资了2家企业，参与招投标项目9次，知识 产权方面有商标信息2条，专利信息39条，此外企业还拥有行政许可25个。 来源：金融界 联合化学最新一期业绩显示，截至2025一季报，公司营业总收入1.30亿元、同比增长0.52%，归属净利 润1654.22万元，同比增长17.97%，扣非净利润1623.00万元，同比增长22.83%，流动比率6.436、速动比 率5.371、资产负债率14.07%。 天眼查商业履历信息显示，龙口联合化学股份有限公司，成立于2007年，位于烟台市，是一家以从事化 学原料和化学制品制造业为 ...

（文章来源：证券日报） 证券日报网讯 8月25日晚间，联合化学发布公告称，公司于2025年8月22日召开职工代表大会，经与会 职工代表审议，同意选举郭浩先生为公司第二届董事会职工代表董事。 ...

Core Viewpoint - The company reported a positive financial performance for the first half of 2025, with significant growth in revenue and net profit, while also expanding its business into the semiconductor materials sector [1][2] Financial Performance - The company achieved operating revenue of 269 million yuan, a year-on-year increase of 4.15% [1] - The net profit attributable to shareholders reached 33.76 million yuan, up 21.62% year-on-year [1] - The net cash flow from operating activities was 44.24 million yuan, reflecting a substantial growth of 105.66% [1] - Basic earnings per share were 0.3014 yuan, an increase of 21.63% compared to the previous year [1] Business Development - In the organic pigment sector, the company focused on new technology development and increased R&D investment, leading to a revenue of 262 million yuan from pigment products, which is a 4.49% increase year-on-year [1] - The gross margin for pigment products was 20.50%, indicating stable growth [1] - The company’s pigment products are recognized for their vibrant colors and excellent performance in both oil-based and water-based inks, achieving domestic leading levels and some products reaching international advanced standards [1] Strategic Expansion - The company is leveraging its technical advantages to enter the semiconductor materials market through its subsidiary, focusing on the development and production of photolithography materials [2] - The initial focus is on high-purity styrene-based photolithography monomers and resins, which are essential for various electronic applications [2] - The company has also invested in Zhaoguangrui Technology to enhance its business portfolio and support domestic high-end manufacturing, particularly in the development of projection exposure machines [2]

格隆汇8月25日丨联合化学(301209.SZ)公布2025年半年度报告，上半年公司实现营业收入2.69亿元，同 比增长4.15%；归属于上市公司股东的净利润3375.70万元，同比增长21.62%；归属于上市公司股东的扣 除非经常性损益的净利润3281.399万元，同比增长12.66%；基本每股收益0.3014元。 ...

龙口联合化学股份有限公司 董事会秘书工作制度 第一章 总 则 第一条 按照建立现代公司制度的要求，为进一步完善龙口联合化学股份有限公司 (以下简称"公司")法人治理结构，明确董事会秘书的权利义务和职责，依照《中华人 民共和国公司法》（以下简称《公司法》）、《深圳证券交易所创业板股票上市规则》 （以下简称《上市规则》）、《龙口联合化学股份有限公司章程》（以下简称《公司章 程》）及其他有关规定，制定本制度。 第二条 公司设董事会秘书 1 名。董事会秘书为公司的高级管理人员，对董事会负责。 董事会秘书应当遵守公司章程，承担高级管理人员的有关法律责任，对公司负有诚信和 勤勉义务，不得利用职权为自己或他人谋取利益。 第二章 董事会秘书的任职资格 第三条 公司董事会秘书的任职资格： 第四条 有下列情形之一的人士不得担任公司董事会秘书： （一）根据《公司法》等法律法规及中国证监会规定、深圳证券交易所规定不得担 任董事、高级管理人员的情形。 （二）最近 36 个月受到中国证监会行政处罚； （三）最近 36 个月受到证券交易所公开谴责或者 3 次以上通报批评； （一）董事会秘书应当具有与履职相匹配的学历文凭，具备一定的从事金融 ...

龙口联合化学股份有限公司 独立董事工作制度 第一章 总 则 第一条 为进一步完善公司法人治理结构，促进公司的规范运作，规范公司 独立董事行为，充分发挥独立董事在公司治理中的作用，根据《中华人民共和国 公司法》（以下简称《公司法》）、《中华人民共和国证券法》、《上市公司独立董事 管理办法》等法律、法规、规范性文件和《公司章程》的有关规定，并结合公司 实际情况，制定本制度。 第二条 独立董事是指不在公司担任除独立董事外的任何其他职务，并与公 司及其主要股东、实际控制人不存在直接或者间接利害关系，或者其他可能影响 其进行独立客观判断关系的董事。 第三条 独立董事对公司及全体股东负有诚信与勤勉的义务。独立董事应当 按照相关法律法规和《公司章程》的要求，认真履行职责，维护公司整体利益， 尤其要关注中小股东的合法权益不受损害，不受与公司存在利害关系的单位或个 人的影响。 独立董事应当独立履行职责，不受公司及其主要股东、实际控制人等单位或 者个人的影响。若发现所审议事项存在影响其独立性的情况，应当向公司申明并 实行回避。任职期间出现明显影响独立性情形的，应当及时通知公司，提出解决 措施，必要时应当提出辞职。 第四条 独立董 ...